 | • レポートコード：GIR-105X12242 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ナロキソンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ナロキソンの種類別市場規模（スプレーフォーム、注射フォーム）、用途別市場規模（ドラッグストア、病院薬局、オンライン）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ナロキソンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：ADAPT Pharma、Amphastar Pharmaceuticals、Pfizer、Kaleo、Sandoz、Amneal Pharmaceuticals、West Ward Pharmaceuticals、Mylan ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：スプレーフォーム、注射フォーム ・用途別分析2016年-2026年：ドラッグストア、病院薬局、オンライン ・ナロキソンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ナロキソンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ナロキソンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ナロキソンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ナロキソンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Naloxone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Naloxone size is estimated to be xx million in 2021 from USD 27580 million in 2020, with a change of XX% between 2020 and 2021. The global Naloxone market size is expected to grow at a CAGR of 2.8% for the next five years.
Market segmentation
Naloxone market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Spray Forms
Injectable Forms
Market segment by Application can be divided into
Drug Store
Hospital Pharmacies
Online
The key market players for global Naloxone market are listed below:
ADAPT Pharma
Amphastar Pharmaceuticals
Pfizer
Kaleo
Sandoz
Amneal Pharmaceuticals
West Ward Pharmaceuticals
Mylan
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Naloxone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Naloxone, with price, sales, revenue and global market share of Naloxone from 2019 to 2021.
Chapter 3, the Naloxone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Naloxone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Naloxone market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Naloxone sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Naloxone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Naloxone Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Spray Forms
1.2.3 Injectable Forms
1.3 Market Analysis by Application
1.3.1 Overview: Global Naloxone Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Drug Store
1.3.3 Hospital Pharmacies
1.3.4 Online
1.4 Global Naloxone Market Size & Forecast
1.4.1 Global Naloxone Sales in Value (2016-2026))
1.4.2 Global Naloxone Sales in Volume (2016-2026)
1.4.3 Global Naloxone Price by Type (2016-2026) & (USD/Unit)
1.5 Global Naloxone Production Capacity Analysis
1.5.1 Global Naloxone Total Production Capacity (2016-2026)
1.5.2 Global Naloxone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Naloxone Market Drivers
1.6.2 Naloxone Market Restraints
1.6.3 Naloxone Trends Analysis
2 Manufacturers Profiles
2.1 ADAPT Pharma
2.1.1 ADAPT Pharma Details
2.1.2 ADAPT Pharma Major Business
2.1.3 ADAPT Pharma Naloxone Product and Services
2.1.4 ADAPT Pharma Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Amphastar Pharmaceuticals
2.2.1 Amphastar Pharmaceuticals Details
2.2.2 Amphastar Pharmaceuticals Major Business
2.2.3 Amphastar Pharmaceuticals Naloxone Product and Services
2.2.4 Amphastar Pharmaceuticals Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Naloxone Product and Services
2.3.4 Pfizer Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Kaleo
2.4.1 Kaleo Details
2.4.2 Kaleo Major Business
2.4.3 Kaleo Naloxone Product and Services
2.4.4 Kaleo Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sandoz
2.5.1 Sandoz Details
2.5.2 Sandoz Major Business
2.5.3 Sandoz Naloxone Product and Services
2.5.4 Sandoz Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Amneal Pharmaceuticals
2.6.1 Amneal Pharmaceuticals Details
2.6.2 Amneal Pharmaceuticals Major Business
2.6.3 Amneal Pharmaceuticals Naloxone Product and Services
2.6.4 Amneal Pharmaceuticals Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 West Ward Pharmaceuticals
2.7.1 West Ward Pharmaceuticals Details
2.7.2 West Ward Pharmaceuticals Major Business
2.7.3 West Ward Pharmaceuticals Naloxone Product and Services
2.7.4 West Ward Pharmaceuticals Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business
2.8.3 Mylan Naloxone Product and Services
2.8.4 Mylan Naloxone Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Naloxone Sales by Manufacturer
3.1 Global Naloxone Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Naloxone Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Naloxone
3.4 Market Concentration Rate
3.4.1 Top 3 Naloxone Manufacturer Market Share
3.4.2 Top 6 Naloxone Manufacturer Market Share
3.5 Global Naloxone Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Naloxone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Naloxone Market Size by Region
4.1.1 Global Naloxone Sales in Volume by Region (2016-2026)
4.1.2 Global Naloxone Revenue by Region (2016-2026)
4.2 North America Naloxone Revenue (2016-2026)
4.3 Europe Naloxone Revenue (2016-2026)
4.4 Asia-Pacific Naloxone Revenue (2016-2026)
4.5 South America Naloxone Revenue (2016-2026)
4.6 Middle East and Africa Naloxone Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Naloxone Sales in Volume by Type (2016-2026)
5.2 Global Naloxone Revenue by Type (2016-2026)
5.3 Global Naloxone Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Naloxone Sales in Volume by Application (2016-2026)
6.2 Global Naloxone Revenue by Application (2016-2026)
6.3 Global Naloxone Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Naloxone Sales by Type (2016-2026)
7.2 North America Naloxone Sales by Application (2016-2026)
7.3 North America Naloxone Market Size by Country
7.3.1 North America Naloxone Sales in Volume by Country (2016-2026)
7.3.2 North America Naloxone Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Naloxone Sales by Type (2016-2026)
8.2 Europe Naloxone Sales by Application (2016-2026)
8.3 Europe Naloxone Market Size by Country
8.3.1 Europe Naloxone Sales in Volume by Country (2016-2026)
8.3.2 Europe Naloxone Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Naloxone Sales by Type (2016-2026)
9.2 Asia-Pacific Naloxone Sales by Application (2016-2026)
9.3 Asia-Pacific Naloxone Market Size by Region
9.3.1 Asia-Pacific Naloxone Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Naloxone Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Naloxone Sales by Type (2016-2026)
10.2 South America Naloxone Sales by Application (2016-2026)
10.3 South America Naloxone Market Size by Country
10.3.1 South America Naloxone Sales in Volume by Country (2016-2026)
10.3.2 South America Naloxone Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Naloxone Sales by Type (2016-2026)
11.2 Middle East & Africa Naloxone Sales by Application (2016-2026)
11.3 Middle East & Africa Naloxone Market Size by Country
11.3.1 Middle East & Africa Naloxone Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Naloxone Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Naloxone Typical Distributors
12.3 Naloxone Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Naloxone Revenue by Type, (USD Million), 2021-2026
Table 2. Global Naloxone Revenue by Application, (USD Million), 2021-2026
Table 3. ADAPT Pharma Basic Information, Manufacturing Base and Competitors
Table 4. ADAPT Pharma Major Business
Table 5. ADAPT Pharma Naloxone Product and Services
Table 6. ADAPT Pharma Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Amphastar Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Amphastar Pharmaceuticals Major Business
Table 9. Amphastar Pharmaceuticals Naloxone Product and Services
Table 10. Amphastar Pharmaceuticals Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Pfizer Basic Information, Manufacturing Base and Competitors
Table 12. Pfizer Major Business
Table 13. Pfizer Naloxone Product and Services
Table 14. Pfizer Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Kaleo Basic Information, Manufacturing Base and Competitors
Table 16. Kaleo Major Business
Table 17. Kaleo Naloxone Product and Services
Table 18. Kaleo Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sandoz Basic Information, Manufacturing Base and Competitors
Table 20. Sandoz Major Business
Table 21. Sandoz Naloxone Product and Services
Table 22. Sandoz Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Amneal Pharmaceuticals Major Business
Table 25. Amneal Pharmaceuticals Naloxone Product and Services
Table 26. Amneal Pharmaceuticals Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. West Ward Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. West Ward Pharmaceuticals Major Business
Table 29. West Ward Pharmaceuticals Naloxone Product and Services
Table 30. West Ward Pharmaceuticals Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Mylan Basic Information, Manufacturing Base and Competitors
Table 32. Mylan Major Business
Table 33. Mylan Naloxone Product and Services
Table 34. Mylan Naloxone Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Naloxone Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Naloxone Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Naloxone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Naloxone Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Naloxone Production Site of Key Manufacturer
Table 40. Naloxone New Entrant and Capacity Expansion Plans
Table 41. Naloxone Mergers & Acquisitions in the Past Five Years
Table 42. Global Naloxone Sales by Region (2016-2021e) & (K Units)
Table 43. Global Naloxone Sales by Region (2021-2026) & (K Units)
Table 44. Global Naloxone Revenue by Region (2016-2021e) & (USD Million)
Table 45. Global Naloxone Revenue by Region (2021-2026) & (USD Million)
Table 46. Global Naloxone Sales by Type (2016-2021e) & (K Units)
Table 47. Global Naloxone Sales by Type (2021-2026) & (K Units)
Table 48. Global Naloxone Revenue by Type (2016-2021e) & (USD Million)
Table 49. Global Naloxone Revenue by Type (2021-2026) & (USD Million)
Table 50. Global Naloxone Price by Type (2016-2021e) & (USD/Unit)
Table 51. Global Naloxone Price by Type (2021-2026) & (USD/Unit)
Table 52. Global Naloxone Sales by Application (2016-2021e) & (K Units)
Table 53. Global Naloxone Sales by Application (2021-2026) & (K Units)
Table 54. Global Naloxone Revenue by Application (2016-2021e) & (USD Million)
Table 55. Global Naloxone Revenue by Application (2021-2026) & (USD Million)
Table 56. Global Naloxone Price by Application (2016-2021e) & (USD/Unit)
Table 57. Global Naloxone Price by Application (2021-2026) & (USD/Unit)
Table 58. North America Naloxone Sales by Country (2016-2021e) & (K Units)
Table 59. North America Naloxone Sales by Country (2021-2026) & (K Units)
Table 60. North America Naloxone Revenue by Country (2016-2021e) & (USD Million)
Table 61. North America Naloxone Revenue by Country (2021-2026) & (USD Million)
Table 62. North America Naloxone Sales by Type (2016-2021e) & (K Units)
Table 63. North America Naloxone Sales by Type (2021-2026) & (K Units)
Table 64. North America Naloxone Sales by Application (2016-2021e) & (K Units)
Table 65. North America Naloxone Sales by Application (2021-2026) & (K Units)
Table 66. Europe Naloxone Sales by Country (2016-2021e) & (K Units)
Table 67. Europe Naloxone Sales by Country (2021-2026) & (K Units)
Table 68. Europe Naloxone Revenue by Country (2016-2021e) & (USD Million)
Table 69. Europe Naloxone Revenue by Country (2021-2026) & (USD Million)
Table 70. Europe Naloxone Sales by Type (2016-2021e) & (K Units)
Table 71. Europe Naloxone Sales by Type (2021-2026) & (K Units)
Table 72. Europe Naloxone Sales by Application (2016-2021e) & (K Units)
Table 73. Europe Naloxone Sales by Application (2021-2026) & (K Units)
Table 74. Asia-Pacific Naloxone Sales by Region (2016-2021e) & (K Units)
Table 75. Asia-Pacific Naloxone Sales by Region (2021-2026) & (K Units)
Table 76. Asia-Pacific Naloxone Revenue by Region (2016-2021e) & (USD Million)
Table 77. Asia-Pacific Naloxone Revenue by Region (2021-2026) & (USD Million)
Table 78. Asia-Pacific Naloxone Sales by Type (2016-2021e) & (K Units)
Table 79. Asia-Pacific Naloxone Sales by Type (2021-2026) & (K Units)
Table 80. Asia-Pacific Naloxone Sales by Application (2016-2021e) & (K Units)
Table 81. Asia-Pacific Naloxone Sales by Application (2021-2026) & (K Units)
Table 82. South America Naloxone Sales by Country (2016-2021e) & (K Units)
Table 83. South America Naloxone Sales by Country (2021-2026) & (K Units)
Table 84. South America Naloxone Revenue by Country (2016-2021e) & (USD Million)
Table 85. South America Naloxone Revenue by Country (2021-2026) & (USD Million)
Table 86. South America Naloxone Sales by Type (2016-2021e) & (K Units)
Table 87. South America Naloxone Sales by Type (2021-2026) & (K Units)
Table 88. South America Naloxone Sales by Application (2016-2021e) & (K Units)
Table 89. South America Naloxone Sales by Application (2021-2026) & (K Units)
Table 90. Middle East & Africa Naloxone Sales by Country (2016-2021e) & (K Units)
Table 91. Middle East & Africa Naloxone Sales by Country (2021-2026) & (K Units)
Table 92. Middle East & Africa Naloxone Revenue by Country (2016-2021e) & (USD Million)
Table 93. Middle East & Africa Naloxone Revenue by Country (2021-2026) & (USD Million)
Table 94. Middle East & Africa Naloxone Sales by Type (2016-2021e) & (K Units)
Table 95. Middle East & Africa Naloxone Sales by Type (2021-2026) & (K Units)
Table 96. Middle East & Africa Naloxone Sales by Application (2016-2021e) & (K Units)
Table 97. Middle East & Africa Naloxone Sales by Application (2021-2026) & (K Units)
Table 98. Direct Channel Pros & Cons
Table 99. Indirect Channel Pros & Cons
Table 100. Naloxone Typical Distributors
Table 101. Naloxone Typical Customers
List of Figures
Figure 1. Naloxone Picture
Figure 2. Global Naloxone Sales Market Share by Type in 2020
Figure 3. Spray Forms
Figure 4. Injectable Forms
Figure 5. Global Naloxone Sales Market Share by Application in 2020
Figure 6. Drug Store
Figure 7. Hospital Pharmacies
Figure 8. Online
Figure 9. Global Naloxone Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Naloxone Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Naloxone Sales (2016-2026) & (K Units)
Figure 12. Global Naloxone Price by Type (2016-2026) & (USD/Unit)
Figure 13. Global Naloxone Production Capacity (2016-2026) & (K Units)
Figure 14. Global Naloxone Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Naloxone Market Drivers
Figure 16. Naloxone Market Restraints
Figure 17. Naloxone Market Trends
Figure 18. Global Naloxone Sales Market Share by Manufacturer in 2020
Figure 19. Global Naloxone Revenue Market Share by Manufacturer in 2020
Figure 20. Naloxone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Naloxone Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Naloxone Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Naloxone Sales Market Share by Region (2016-2026)
Figure 24. Global Naloxone Revenue Market Share by Region (2016-2026)
Figure 25. North America Naloxone Revenue (2016-2026) & (USD Million)
Figure 26. Europe Naloxone Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Naloxone Revenue (2016-2026) & (USD Million)
Figure 28. South America Naloxone Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Naloxone Revenue (2016-2026) & (USD Million)
Figure 30. Global Naloxone Sales Market Share by Type (2016-2026)
Figure 31. Global Naloxone Revenue Market Share by Type (2016-2026)
Figure 32. Global Naloxone Price by Type (2016-2026) & (USD/Unit)
Figure 33. Global Naloxone Sales Market Share by Application (2016-2026)
Figure 34. Global Naloxone Revenue Market Share by Application (2016-2026)
Figure 35. Global Naloxone Price by Application (2016-2026) & (USD/Unit)
Figure 36. North America Naloxone Sales Market Share by Type (2016-2026)
Figure 37. North America Naloxone Sales Market Share by Application (2016-2026)
Figure 38. North America Naloxone Sales Market Share by Country (2016-2026)
Figure 39. North America Naloxone Revenue Market Share by Country (2016-2026)
Figure 40. United States Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Naloxone Sales Market Share by Type (2016-2026)
Figure 44. Europe Naloxone Sales Market Share by Application (2016-2026)
Figure 45. Europe Naloxone Sales Market Share by Country (2016-2026)
Figure 46. Europe Naloxone Revenue Market Share by Country (2016-2026)
Figure 47. Germany Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Naloxone Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Naloxone Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Naloxone Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Naloxone Revenue Market Share by Region (2016-2026)
Figure 56. China Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Naloxone Sales Market Share by Type (2016-2026)
Figure 63. South America Naloxone Sales Market Share by Application (2016-2026)
Figure 64. South America Naloxone Sales Market Share by Country (2016-2026)
Figure 65. South America Naloxone Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Naloxone Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Naloxone Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Naloxone Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Naloxone Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Naloxone Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界のナロキソンスプレー市場 2021：企業別、地域別、種類・用途別 The Naloxone Spray market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…- ナロキソン塩酸塩の世界市場2018-2025 Naloxone Hydrochloride is the hydrochloride salt of naloxone, a thebaine derivate with opioid antagonist activity.In 2018, the global Naloxone Hydrochloride market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. In this study, 2017 has been consi…
- マステクトミーの世界市場2018-2025 Feel confident and wholesome at all times with our range of mastectomy breast forms. Discover a full range of breast forms that offer you a natural feel. These products are made of soft and fine quality fabric which protects the sensitive skin of the user and gives her a sense of security. Mastectom…
- OTC外用薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 世界のモノクローナル抗体滅菌注射薬市場 2021：企業別、地域別、種類・用途別 The Monoclonal Antibodies Sterile Injectable Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…